Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

122.71
Delayed Data
As of 3:59pm ET
 +1.73 / +1.43%
Today’s Change
97.52
Today|||52-Week Range
169.89
-14.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues369.0M412.6M408.2M409.0M
 
 
 
 
 
Cost of Goods Sold700.0K12.1M15.4M20.6M
 
 
 
 
 
Depreciation And Amortization--7.9M8.2M7.8M
 
 
 
 
 
Operating ExpensesGross Income368.3M392.6M384.6M380.6M
 
 
 
 
 
General Expenses4.6M107.4M146.0M206.4M
 
 
 
 
 
Research And Development-400.0K35.2M45.9M66.9M
 
 
 
 
 
Total Operating Expenses5.3M127.4M169.6M234.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income363.7M285.2M238.6M174.2M
 
 
 
 
 
Interest Expense On Debt600.0K600.0K500.0K2.2M
 
 
 
 
 
Other Expenses800.0K1.1M1.0M-500.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income363.9M285.7M239.1M171.5M
 
 
 
 
 
Income Taxes-128.4M-79.6M-77.3M-61.2M
 
 
 
 
 
Net Income235.5M206.1M161.8M110.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.4M44.3M43.2M42.2M
 
 
 
 
 
Shares To Calculate EPS Diluted48.7M46.9M46.2M45.4M
 
 
 
 
 
 
Earnings Per ShareEPS$4.84$4.39$3.50$2.43
 
 
 
 
 
EPS Diluted$4.84$4.39$3.50$2.43